Pearl River Capital, LLC Sarepta Therapeutics, Inc. Transaction History

Pearl River Capital, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$93.7 - $141.53 $674,265 - $1.02 Million	7,196 New	7,196 $931,000
Q2 2022 Aug 12, 2022	BUY	$62.69 - $88.44 $269,316 - $379,938	4,296 Added 87.25%	9,220 $691,000
Q1 2022 May 13, 2022	SELL	$63.15 - $90.42 $411,232 - $588,815	-6,512 Reduced 56.94%	4,924 $385,000
Q4 2021 Feb 11, 2022	BUY	$77.28 - $99.42 $681,764 - $877,083	8,822 Added 337.49%	11,436 $1.03 Million
Q4 2019 Feb 12, 2020	BUY	$76.53 - $135.58 $200,049 - $354,406	2,614 New	2,614 $337,000
Q2 2019 Aug 12, 2019	SELL	$112.21 - $151.95 $137,569 - $186,290	-1,226 Closed	0 $0
Q1 2019 May 02, 2019	BUY	$106.67 - $151.68 $109,443 - $155,623	1,026 Added 513.0%	1,226 $146,000
Q4 2018 Feb 08, 2019	BUY	$97.32 - $148.76 $19,464 - $29,752	200 New	200 $22,000

534

85.3M

1.55M

1.35M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $5.59B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Pearl River Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Pearl River Capital, LLC with notifications on news.